Longitudinal changes in patient-reported outcomes after artificial urinary sphincter implantation.


Journal

Lower urinary tract symptoms
ISSN: 1757-5672
Titre abrégé: Low Urin Tract Symptoms
Pays: Australia
ID NLM: 101506777

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 22 02 2020
revised: 10 03 2020
accepted: 30 03 2020
pubmed: 14 4 2020
medline: 16 7 2021
entrez: 14 4 2020
Statut: ppublish

Résumé

To evaluate the time course of lower urinary tract symptoms (LUTS) after artificial urinary sphincter (AUS) implantation based on individual longitudinal changes of patient-reported outcomes. This retrospective study included 66 male patients with severe urinary incontinence who were treated with primary AUS implantation between 2009 and 2019. International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and International Prostate Symptom Score (IPSS) questionnaires were used to evaluate continence status and LUTS preoperatively, 1, 3, and 12 months after activation, and then annually. The annual changes in scores were calculated with a linear mixed model. Of the 66 patients, 63 (95%) achieved complete or social continence (number of pads used ≤1/d) at 1 month after activation. Mean preoperative ICIQ-SF, IPSS, and IPSS-quality of life (QOL) score were 18.9, 14.9, and 5.4, respectively; the corresponding scores at 1 month after activation were 4.5, 9.0, and 1.7 (all P < .001), respectively. During the mean follow-up period of 36 months, the annual changes in the scores from 1 month after activation were 0.51 (P = .002), -0.30 (P = .184), and 0.19 (P < .001), respectively. As for individual IPSS items, while incomplete emptying, frequency, urgency, and weak stream improved significantly 1 month after activation, no significant changes from 1 month after activation were observed except for longitudinal deterioration of incomplete emptying score (0.08/y, P = .029). Continence status and QOL score markedly improved by AUS implantation immediately, but deteriorated over time. Improved LUTS were maintained without a worsening trend, however.

Identifiants

pubmed: 32281740
doi: 10.1111/luts.12311
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

240-244

Informations de copyright

© 2020 John Wiley & Sons Australia, Ltd.

Références

Scott FB, Bradley WE, Timm GW. Treatment of urinary incontinence by implantable prosthetic sphincter. Urology. 1973;1:252-259.
Burkhard FC, Bosch JLHR, Cruz F, et al. 2020 EAU Guidelines on Urinary incontinence in adults. Available at: https://uroweb.org/guideline/urinary-incontinence/#4. Accessed January 28, 2020.
Imamoglu MA, Tuygun C, Bakirtas H, Yiğitbasi O, Kiper A. The comparison of artificial urinary sphincter implantation and endourethral macroplastique injection for the treatment of postprostatectomy incontinence. Eur Urol. 2005;47:209-213.
Trigo Rocha F, Gomes CM, Mitre AI, Arap S, Srougi M. A prospective study evaluating the efficacy of the artificial sphincter AMS 800 for the treatment of postradical prostatectomy urinary incontinence and the correlation between preoperative urodynamic and surgical outcomes. Urology. 2008;71:85-89.
Léon P, Chartier-Kastler E, Rouprêt M, Ambrogi V, Mozer P, Phé V. Long-term functional outcomes after artificial urinary sphincter implantation in men with stress urinary incontinence. BJU Int. 2015;115:951-957.
Linder BJ, Rivera ME, Ziegelmann MJ, Elliott DS. Long-term outcomes following artificial urinary sphincter placement: an analysis of 1082 cases at Mayo Clinic. Urology. 2015;86:602-607.
Kaiho Y, Masuda H, Takei M, et al. Surgical and patient reported outcomes of artificial urinary sphincter implantation: a multicenter, prospective, observational study. J Urol. 2018;199:245-250.
Viers BR, Linder BJ, Rivera ME, Rangel LJ, Ziegelmann MJ, Elliott DS. Long-term quality of life and functional outcomes among primary and secondary artificial urinary sphincter implantations in men with stress urinary incontinence. J Urol. 2016;196:838-843.
Holm HV, Fosså SD, Hedlund H, Dahl AA. Study of generic quality of life in patients operated on for post-prostatectomy incontinence. Int J Urol. 2013;20:889-895.
Afraa TA, Campeau L, Mahfouz W, Corcos J. Urodynamic parameters evolution after artificial urinary sphincter implantation for post-radical prostatectomy incontinence with concomitant bladder dysfunction. Can J Urol. 2011;18:5695-5698.
Gomha MA, Boone TB. Artificial urinary sphincter for post-prostatectomy incontinence in men who had prior radiotherapy: a risk and outcome analysis. J Urol. 2002;167:591-596.
Sathianathen NJ, McGuigan SM, Moon DA. Outcomes of artificial urinary sphincter implantation in the irradiated patient. BJU Int. 2014;113:636-641.
Ravier E, Fassi-Fehri H, Crouzet S, Gelet A, Abid N, Martin X. Complications after artificial urinary sphincter implantation in patients with or without prior radiotherapy. BJU Int. 2015;115:300-307.
Walsh IK, Williams SG, Mahendra V, Nambirajan T, Stone AR. Artificial urinary sphincter implantation in the irradiated patient: safety, efficacy and satisfaction. BJU Int. 2002;89:364-368.
Bates AS, Martin RM, Terry TR. Complications following artificial urinary sphincter placement after radical prostatectomy and radiotherapy: a meta-analysis. BJU Int. 2015;116:623-633.
Guillaumier S, Solomon E, Jenks J, et al. Radiotherapy is associated with reduced continence outcomes following implantation of the artificial urinary sphincter in men with post-radical prostatectomy incontinence. Urol Ann. 2017;9:253-256.
Adam M, Tennstedt P, Lanwehr D, et al. Functional outcomes and quality of life after radical prostatectomy only versus a combination of prostatectomy with radiation and hormonal therapy. Eur Urol. 2017;71:330-336.
Miyake M, Tanaka N, Asakawa I, et al. Changes in lower urinary tract symptoms and quality of life after salvage radiotherapy for biochemical recurrence of prostate cancer. Radiother Oncol. 2015;115:321-326.
Ervandian M, Djurhuus JC, Høyer M, Graugaard-Jensen C, Borre M. Long-term urodynamic findings following radical prostatectomy and salvage radiotherapy. Scand J Urol. 2018;52:20-26.

Auteurs

Minato Yokoyama (M)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Hitoshi Masuda (H)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Urology, National Cancer Center Hospital East, Kashiwa, Japan.

Masaya Ito (M)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.

Yuma Waseda (Y)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Urology, Tokyo Metropolitan Ohtsuka Hospital, Tokyo, Japan.

Shingo Moriyama (S)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Masahiro Toide (M)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Yusuke Uchida (Y)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Sho Uehara (S)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Toshiki Kijima (T)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Soichiro Yoshida (S)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Junichiro Ishioka (J)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Yoh Matsuoka (Y)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Kazutaka Saito (K)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Yasuhisa Fujii (Y)

Department of Urology, Tokyo Medical and Dental University, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH